Paper

Cost-effectiveness of atorvastatin in the prevention of cardiovascular events in diabetic patients: a French adaptation of CARDS.

Published May 1, 2008 · A. Lafuma, X. Colin, A. Solesse

Archives of cardiovascular diseases

Citations

Influential Citations

Abstract

Abstract removed due to Elsevier request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

Study Snapshot

Key takeawayAtorvastatin is cost-effective in primary prevention of cardiovascular disease in patients with type 2 diabetes, falling within the current acceptance threshold.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Cost-effectiveness of atorvastatin in the prevention of cardiovascular events in diabetic patients: a French adaptation of CARDS.

References

Citations